These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10563197)

  • 1. A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.
    Adachi S; Ogasawara T; Yamasaki N; Shibahara H; Kanazawa R; Tsuji Y; Takemura T; Koyama K
    Jpn J Clin Oncol; 1999 Sep; 29(9):434-7. PubMed ID: 10563197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
    Sugiyama T; Okamoto A; Enomoto T; Hamano T; Aotani E; Terao Y; Suzuki N; Mikami M; Yaegashi N; Kato K; Yoshikawa H; Yokoyama Y; Tanabe H; Nishino K; Nomura H; Kim JW; Kim BG; Pignata S; Alexandre J; Green J; Isonishi S; Terauchi F; Fujiwara K; Aoki D
    J Clin Oncol; 2016 Aug; 34(24):2881-7. PubMed ID: 27400948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.
    Takakura S; Takano M; Takahashi F; Saito T; Aoki D; Inaba N; Noda K; Sugiyama T; Ochiai K;
    Int J Gynecol Cancer; 2010 Feb; 20(2):240-7. PubMed ID: 20169667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
    Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma.
    Takakura S; Saito M; Ueda K; Motegi M; Takao M; Yamada K; Okamoto A; Niimi S; Sasaki H; Tanaka T; Ochiai K
    Int Surg; 2007; 92(4):202-8. PubMed ID: 18050828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.
    Nishino K; Aoki Y; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2005 Jun; 97(3):893-7. PubMed ID: 15894369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer.
    Sugiyama T; Yakushiji M; Nishida T; Ushijima K; Okura N; Kigawa J; Terakawa N
    Cancer Lett; 1998 Jun; 128(2):211-8. PubMed ID: 9683285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.
    Shirao K; Shimada Y; Kondo H; Saito D; Yamao T; Ono H; Yokoyama T; Fukuda H; Oka M; Watanabe Y; Ohtsu A; Boku N; Fujii T; Oda Y; Muro K; Yoshida S
    J Clin Oncol; 1997 Mar; 15(3):921-7. PubMed ID: 9060529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Kusunoki Y; Matsui K; Nakagawa K; Hirashima T; Tamanoi M; Nitta T; Yana T
    J Clin Oncol; 1994 Jan; 12(1):90-6. PubMed ID: 7505810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of clear cell adenocarcinoma of the ovary (OCCA) with a combination of CPT-11 and mitomycin C].
    Shimizu Y; Umezawa S; Hasumi K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):587-93. PubMed ID: 8678517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.
    Sugiyama T; Yakushiji M; Kamura T; Ikeda M; Umesaki N; Hasegawa K; Ishikawa M; Saji F; Hiura M; Takahashi T; Sato S; Ochiai K; Kikkawa F; Takeuchi S; Ohashi Y; Noda K;
    Oncology; 2002; 63(1):16-22. PubMed ID: 12187066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.
    Shimizu Y; Umezawa S; Hasumi K
    Ann Acad Med Singap; 1998 Sep; 27(5):650-6. PubMed ID: 9919334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile.
    Nakano T; Chahinian AP; Shinjo M; Togawa N; Tonomura A; Miyake M; Ninomiya K; Yamamoto T; Higashino K
    Cancer; 1999 Jun; 85(11):2375-84. PubMed ID: 10357408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.
    Kudoh S; Fukuoka M; Masuda N; Yoshikawa A; Kusunoki Y; Matsui K; Negoro S; Takifuji N; Nakagawa K; Hirashima T
    Jpn J Cancer Res; 1995 Apr; 86(4):406-13. PubMed ID: 7775263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer.
    Kobayashi K; Shinbara A; Kamimura M; Takeda Y; Kudo K; Kabe J; Hibino S; Hino M; Shibuya M; Kudoh S
    Cancer Chemother Pharmacol; 1998; 42(1):53-8. PubMed ID: 9619758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with irinotecan hydrochloride (CPT-11) and mitomycin C in platinum-refractory ovarian cancer.
    Aoki Y; Kurata H; Watanabe M; Fujita K; Tanaka K
    Am J Clin Oncol; 2004 Oct; 27(5):461-4. PubMed ID: 15596911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
    Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
    Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].
    Takami M; Kita E; Kuwana Y; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Ichikawa G; Yamamoto T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1243-5. PubMed ID: 18633273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
    Takano M; Kikuchi Y; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Sugiyama T
    Oncol Rep; 2006 Dec; 16(6):1301-6. PubMed ID: 17089053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.